APA (7th ed.) Citation

Delaveris, C. S., Wilk, A. J., Riley, N. M., Stark, J. C., Yang, S. S., Rogers, A. J., . . . Bertozzi, C. R. (2021). Synthetic Siglec‑9 Agonists Inhibit Neutrophil Activation Associated with COVID-19. ACS central science, 7(4), 650-657. https://doi.org/10.1021/acscentsci.0c01669

Chicago Style (17th ed.) Citation

Delaveris, Corleone S., et al. "Synthetic Siglec‑9 Agonists Inhibit Neutrophil Activation Associated with COVID-19." ACS Central Science 7, no. 4 (2021): 650-657. https://doi.org/10.1021/acscentsci.0c01669.

MLA (9th ed.) Citation

Delaveris, Corleone S., et al. "Synthetic Siglec‑9 Agonists Inhibit Neutrophil Activation Associated with COVID-19." ACS Central Science, vol. 7, no. 4, 2021, pp. 650-657, https://doi.org/10.1021/acscentsci.0c01669.